FDA
Dalfampridine
The FDA lists this product in 9 strengths and forms.
Composition
- Active ingredients
- DALFAMPRIDINE 10MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- DALFAMPRIDINE 10MG · Tablet, extended releaseANDA206854-001 · Tentative approval
- DALFAMPRIDINE 10MG · Tablet, extended releaseANDA206858-001 · Discontinued
- DALFAMPRIDINE 10MG · Tablet, extended releaseANDA210158-001 · Prescription
- DALFAMPRIDINE 10MG · Tablet, extended releaseANDA206811-001 · Prescription
- DALFAMPRIDINE 10MG · Tablet, extended releaseANDA206863-001 · Prescription
- DALFAMPRIDINE 10MG · Tablet, extended releaseANDA208292-001 · Discontinued
- DALFAMPRIDINE 10MG · Tablet, extended releaseThis page
- DALFAMPRIDINE 10MG · Tablet, extended releaseANDA206765-001 · Prescription
- DALFAMPRIDINE 10MG · Tablet, extended releaseANDA206836-001 · Prescription
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA206646.
At a glance
- Brand name
- Dalfampridine
- Route
- Oral
- Dosage form
- Tablet, extended release
- Applicant
- Hikma
- Status
- Discontinued
- FDA approval
- 24 Oct 2018
- Application
- ANDA206646-001